Stephen Mok - Concepedia

Concepedia

Author

Stephen Mok

University of California, Los Angeles

Also Known As

S. Mok, S.F. Mok, Stephen Mok

117

Publications

4.6K

Citations

18

H-Index

32

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Institute for Molecular Medicine Plexxikon (United States)UCLA Medical Center

SM

About

Stephen Mok is an author at University of California, Los Angeles specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Immunology	5	5	788
3	Cell Biology	4	4	903
4	Allergy	1	1	91
5	Cellular Therapies	1	1	311

Stephen Mok

×

19

Publications

4.6K

Citations

17

H-Index

	Year	Citations
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors Fei Su, Amaya Virós, Carla Milagre, New England Journal of Medicine	2012	1K
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma Siwen Hu‐Lieskovan, Stephen Mok, Blanca Homet Moreno, Science Translational Medicine	2015	562
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer Jingying Xu, Jemima Escamilla, Stephen Mok, Cancer Research	2013	552
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire Lídia Robert, Jennifer Tsoi, Xiaoyan Wang, Clinical Cancer Research	2014	366
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, Cancer Research	2015	317
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy Stephen Mok, Richard C. Koya, Christopher Tsui, Cancer Research Cell TherapyTyrosine KinaseImmunologyImmune RegulationAntitumor Efficacy	2013	311
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors Deborah A. Knight, Shin Foong Ngiow, Ming Li, Journal of Clinical Investigation	2013	270
BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy Richard C. Koya, Stephen Mok, Nicholas Otte, Cancer Research Adoptive Cell ImmunotherapyTumor ImmunologyAntitumor ActivityTransferred CellsCancer Immunosurveillance	2012	232
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032 Jonas Nørskov Søndergaard, Ramin Nazarian, Qi Wang, Journal of Translational Medicine Cancer BiologyTumor BiologyCancer Cell BiologyMolecular DiagnosticsRadiation Oncology	2010	224
CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans Rong Huang, Jason Jalil, James S. Economou, Clinical Cancer Research	2011	151

Page 1